DiabetesHealth – FDA Approves Once-weekly Trulicity to Treat Type 2 Diabetes

Also known as dulaglutide, Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps normalize blood sugar levels by encouraging the release of insulin, which helps the body better use available blood glucose, while suppressing the stimulation of glucose production.

Read more

Posted in Type II Drugs